This study, being conducted in South Africa, is similar to ImmunityBio’s U.S.-based trial QUILT 3.092, a phase 1 open-label study of CD19 t-haNK as a single agent and in combination with the company’s ...

Dupixent significantly reduced itch and hive activity from baseline; 41% of patients achieved well-controlled disease statusConfirmatory data to ...

A study uncovers IL-1β signaling in cardiac fibrosis, highlighting distinct fibroblast populations and promising ...

After an injury to the elbow, such as a fracture or dislocation, the joint may stiffen and be difficult to move, making ...

When compared with placebo, vunakizumab is a safe and efficacious treatment for moderate to severe plaque psoriasis among adults.

Eschewing the notion that less is more with a vengeance, Parker Finn’s “Smile 2” is everything his surprise 2022 hit was not. Loud, bloated and gratuitous, the sequel stumbles into ...

A second person, traveling with the man on a separate watercraft, declined medical treatment at the scene, according to a news release from Nunda Rural Fire Protection District. The first responders ...

Online sports betting is bringing in new revenue for New Jersey, but it is also ...

Sequencing giant Illumina Inc. ILMN is set to release third-quarter 2024 results on Nov. 4 after the closing bell. Stay up-to ...

A new study being presented at this year’s ACAAI Annual Scientific Meeting showed that, in Chicago, there has been a significant increase in sensitization to pollens and molds in patients with nasal ...

The Phase 1b/2 readout in pulmonary sarcoidosis was not all too promising as it had failed to ... That assumption is probably ...

Chicago's health department urged anyone who has eaten a McDonald's Quarter Pounder hamburger and experienced E. coli ...